Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
BMC Psychiatry ; 21(1): 623, 2021 12 11.
Artículo en Inglés | MEDLINE | ID: mdl-34895185

RESUMEN

BACKGROUND: The neurodevelopmental model of obsessive-compulsive disorder (OCD) suggests that the neurodevelopmental changes in the ventral striatal circuit of the prefrontal lobe are associated with the initial symptoms of OCD. Facial morphology is one of the most consistent anatomical phenotypes of neurodevelopmental disorders, which can reflect brain structure and function. Facial deformity, an easily measured index of brain malformation, can reflect abnormal brain structure and function. Therefore, this study aims to explore the relationship between clinical features and neurodevelopment of adolescents with OCD through facial morphology. METHODS: The enrolled study sample comprised 40 adolescents diagnosed with OCD using the Obsessive Compulsive Inventory-Child Version (OCI-CV) and 38 healthy controls (HCs). Facial photos, 21 facial diameters, and 9 facial angles were collected using image software. RESULTS: In males, lower lip red height was significantly lower in OCD patients than in HCs (P < 0.025); no significant differences were observed in other facial indicators (all P > 0.025). In females, the nasolabial angle was smaller in OCD patients than in HCs (P < 0.025); no significant differences were observed in other facial indicators (all P > 0.025). The difference in lower lip red height between the OCD group and HC group was positively correlated with neutralizing symptoms (r = 0.401, P < 0.05). CONCLUSIONS: Male OCD patients had a thinner lower lip and female OCD patients had smaller nasolabial angles. The facial features of adolescents with OCD were positively correlated with lower lip redness and neutralizing symptoms.


Asunto(s)
Trastorno Obsesivo Compulsivo , Adolescente , Encéfalo , Femenino , Humanos , Masculino , Trastorno Obsesivo Compulsivo/diagnóstico
2.
Entropy (Basel) ; 21(1)2019 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-33266785

RESUMEN

Soil depth plays an important role in landslide disaster prevention and is a key factor in slopeland development and management. Existing soil depth maps are outdated and incomplete in Taiwan. There is a need to improve the accuracy of the map. The Kriging method, one of the most frequently adopted estimation approaches for soil depth, has room for accuracy improvements. An appropriate soil depth estimation method is proposed, in which soil depth is estimated using Bayesian Maximum Entropy method (BME) considering space distribution of measured soil depth and impact of physiographic factors. BME divides analysis data into groups of deterministic and probabilistic data. The deterministic part are soil depth measurements in a given area and the probabilistic part contains soil depth estimated by a machine learning-based soil depth estimation model based on physiographic factors including slope, aspect, profile curvature, plan curvature, and topographic wetness index. Accuracy of estimates calculated by soil depth grading, very shallow (<20 cm), shallow (20-50 cm), deep (50-90 cm), and very deep (>90 cm), suggests that BME is superior to the Kriging method with estimation accuracy up to 82.94%. The soil depth distribution map of Hsinchu, Taiwan made by BME with a soil depth error of ±5.62 cm provides a promising outcome which is useful in future applications, especially for locations without soil depth data.

3.
Mol Pharmacol ; 82(2): 189-98, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22553359

RESUMEN

Protein kinase B/AKT kinase is the core component of the phosphatidylinositol 3-kinase/AKT signaling pathway, which is frequently hyperactivated in human cancers. We designed and synthesized a series of 2-pyrimidyl-5-amidothiazole compounds based on the ATP binding site of AKT, and the most potent compound, (S)-N-(1-amino-3-(2,4-dichlorophenyl)propan-2-yl)-2-(2-(methylamino)pyrimidin-4-yl)thiazole-5-carboxamide (DC120), was identified to inhibit AKT activity in vitro with an EC(50) of 153 nM by a fluorescence resonance energy transfer-based Z'-LYTE assay. The antitumor effect of DC120 was tested on human CNE2 and MDA-MB-453 cell lines and the CNE2 xenograft model. The results showed that DC120 could obviously inhibit the proliferation of CNE2 and MDA-MB-453 cells via induction of apoptosis, with the evidence of increases in sub-G(1) and annexin V-positive cells, characteristic morphologic changes of apoptosis in the nucleus, and cleaved caspase-3. Further study showed that MDA-MB-453 cells transfected with constitutively activated AKT1 were more sensitive to DC120,whereas CNE2 cells with knockdown of AKT1 expression by short hairpin RNA were more resistant to DC120. Of more importance, DC120 partially attenuated the phosphorylation levels of forkhead transcription factor (FKHR), FKHRL1, glycogen synthase kinase 3ß, and mammalian target of rapamycin in a dose-dependent and time-dependent fashion and led to an increase in the nuclear accumulation of exogenous FKHR in cancer cells. In addition, DC120 at 20 mg/kg/day inhibited the CNE2 xenograft tumor growth with a treated group/control group ratio of 38.1%, accompanied by increasing terminal deoxynucleotidyl transferasedUTP nick-end labeling-positive cells in the tumor sample. In addition, DC120 induced a feedback loop to activate the mitogen-activated protein kinase pathway and treatment with mitogen-activated protein kinase kinase inhibitor 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) and DC120 synergistically induced cancer cell apoptosis. These data provide validation for the development of DC120 to treat cancers displaying elevated levels of AKT.


Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Proto-Oncogénicas c-akt/antagonistas & inhibidores , Pirimidinas/farmacología , Tiazoles/farmacología , Animales , Antineoplásicos/química , Apoptosis/fisiología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Humanos , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Inhibidores de Proteínas Quinasas/química , Proteínas Proto-Oncogénicas c-akt/fisiología , Pirimidinas/química , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Tiazoles/química , Ensayos Antitumor por Modelo de Xenoinjerto/métodos
4.
Perspect Psychiatr Care ; 54(1): 31-38, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27861956

RESUMEN

PURPOSE: This study aimed to determine the prevalence and the socio-demographic and clinical correlates of sleep disturbance in first-episode individuals with schizophrenia in rural China and the factors that impact sleep among individuals with schizophrenia. DESIGN AND METHODS: A total of 104 first-episode individuals with schizophrenia were randomly selected in rural areas in Ningxia, China, in 2015 as the study sample. FINDINGS: In first-episode individuals with schizophrenia, the prevalence of sleep disturbance was 78.8% (82/104). Sleep disturbance was significantly associated with economic status, living situation, educational level, depressive symptoms, and anxiety symptoms. PRACTICE IMPLICATIONS: Sleep disturbance is common in first-episode individuals with schizophrenia in rural China and more attention should be paid in clinical practice to improve the sleep quality for individuals with schizophrenia.


Asunto(s)
Ansiedad/epidemiología , Depresión/epidemiología , Población Rural/estadística & datos numéricos , Esquizofrenia/epidemiología , Trastornos del Sueño-Vigilia/epidemiología , Factores Socioeconómicos , Adulto , China/epidemiología , Comorbilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA